^Eison AS (1990). „Azapirones: history of development”. Journal of Clinical Psychopharmacology. 10 (3 Suppl): 2S—5S. PMID1973936.
^Cadieux RJ (1996). „Azapirones: an alternative to benzodiazepines for anxiety”. American Family Physician. 53 (7): 2349—53. PMID8638511.
^Chessick CA, Allen MH, Thase M (2006). Chessick CA, ур. „Azapirones for generalized anxiety disorder”. Cochrane Database of Systematic Reviews (Online). 3: CD006115. PMID16856115. doi:10.1002/14651858.CD006115.
^Bouwer C, Stein DJ (1997). „Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression”. South African Medical Journal. 87 (4 Suppl): 534—7, 540. PMID9180827.
^Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH (2001). „Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study”. The Journal of Clinical Psychiatry. 62 (6): 448—52. PMID11465522. doi:10.4088/JCP.v62n0608.